ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

OCGN Company Profile and Key Details

NASDAQ : OCGN

Ocugen, Inc.

$0.69

0.1107+18.99%

At Close 4:00 PM

66.82

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

OCGN Stock Price Chart

Stock Price Today

Ocugen, Inc. (OCGN) stock surged +18.99%, trading at $0.69 on NASDAQ, up from the previous close of $0.58. The stock opened at $0.60, fluctuating between $0.57 and $0.72 in the recent session.

Stock Snapshot

0.5828

Prev. Close

0.6

Open

202.51M

Market Cap

292.01M

Number of Shares

0.57

Day Low

0.7196

Day High

-3.47

P/E Ratio

98.2%

Free Float in %

-0.2

EPS (TTM)

0.16

Book Value

-0.28

Cash Flow per Share

6.63M

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 09, 2025	0.59	0.72	0.57	0.69	6.63M
Apr 08, 2025	0.64	0.66	0.58	0.58	3.07M
Apr 07, 2025	0.60	0.67	0.59	0.65	5.29M
Apr 04, 2025	0.61	0.69	0.61	0.66	3.8M
Apr 03, 2025	0.66	0.67	0.62	0.64	3.72M
Apr 02, 2025	0.65	0.71	0.63	0.69	3.58M
Apr 01, 2025	0.70	0.72	0.64	0.65	3.38M
Mar 31, 2025	0.76	0.77	0.68	0.71	5.3M
Mar 28, 2025	0.71	0.80	0.70	0.80	6.99M
Mar 27, 2025	0.75	0.75	0.69	0.72	3.23M
Mar 26, 2025	0.74	0.74	0.71	0.74	4.08M
Mar 25, 2025	0.68	0.72	0.64	0.71	6.05M
Mar 24, 2025	0.62	0.64	0.61	0.64	2.78M
Mar 21, 2025	0.58	0.61	0.56	0.60	4.03M
Mar 20, 2025	0.54	0.59	0.53	0.58	4.11M
Mar 19, 2025	0.52	0.55	0.52	0.55	2.65M
Mar 18, 2025	0.56	0.57	0.52	0.52	6.66M
Mar 17, 2025	0.56	0.58	0.55	0.57	2.4M
Mar 14, 2025	0.55	0.57	0.54	0.54	2.76M
Mar 13, 2025	0.57	0.58	0.54	0.54	2.03M

Contact Details

Malvern, PA 19355

United States

Website: https://www.ocugen.comContact: 484 328 4701

About Company

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Frequently Asked Questions

What is the current Ocugen, Inc. (OCGN) stock price?

Ocugen, Inc. (NASDAQ: OCGN) stock price is $0.69 in the last trading session. During the trading session, OCGN stock reached the peak price of $0.72 while $0.57 was the lowest point it dropped to. The percentage change in OCGN stock occurred in the recent session was 18.99% while the dollar amount for the price change in OCGN stock was $0.11.

OCGN's industry and sector of operation?

The NASDAQ listed OCGN is part of Biotechnology industry that operates in the broader Healthcare sector. Ocugen, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OCGN?

Mr. Quan Anh Vu
Chief Operating Officer & Chief Bus. Officer
Dr. Arun Upadhyay Ph.D.
Chief Scientific Officer and Head of Research, Devel. & Medical
Jyothy Pillai
Head of Regulatory & Quality
Ms. Jessica Crespo C.P.A., CPA
Chief Accounting Officer, Senior Vice President of Fin. and VP of Corporation Controller & Treasurer
Dr. Shankar Musunuri M.B.A., MBA, Ph.D.
Co-Founder, Chairman & Chief Executive Officer
Dr. Uday B. Kompella Ph.D.
Co-founder & Independent Director
Mr. Michael Shine M.B.A.
Senior Vice President of Commercial
Dr. Vijay Tammara Ph.D.
Senior Vice President of Regulatory & Quality
Dr. Robert J. Hopkins FACP, M.D., M.P.H.
Chief Medical Officer
Ms. Tiffany Hamilton M.B.A.
Head of Corporation Communications
Mr. Michael Shine
Senior Vice President of Commercial
Ms. Tiffany J. Hamilton M.B.A.
Head of Corporation Communications
Ms. Zara Gaudioso
AVice President, Head of HR & Chief of Staff
Ms. Jessica Crespo CPA, CPA
Chief Accounting Officer, Senior Vice President of Fin. and VP of Corporation Controller & Treasurer
Ms. Jyothy Pillai M.S.
Head of Regulatory & Quality
Dr. Huma Qamar CMI, M.D., M.P.H.
Head of Clinical Devel. & Medical Affairs

How OCGN did perform over past 52-week?

OCGN's closing price is 34.66% higher than its 52-week low of $0.52 where as its distance from 52-week high of $2.06 is -66.33%.

How many employees does OCGN have?

Number of OCGN employees currently stands at 95.

Link for OCGN official website?

Official Website of OCGN is: https://www.ocugen.com

How do I contact OCGN?

OCGN could be contacted at phone 484 328 4701 and can also be accessed through its website. OCGN operates from 263 Great Valley Parkway, Malvern, PA 19355, United States.

How many shares of OCGN are traded daily?

OCGN stock volume for the day was 6.63M shares. The average number of OCGN shares traded daily for last 3 months was 4.03M.

What is the market cap of OCGN currently?

The market value of OCGN currently stands at $202.51M with its latest stock price at $0.69 and 292.01M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	95
Beta	3.89
Sales or Revenue	$6.04M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology